Compare Stocks: APH, MRV, VRX, and APHA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APH Amphenol	$157.90 -1.7%	$155.61	$104.71 ▼ $178.52	$194.26B	1.24	9.61 million shs	496,454 shs
APHA Aphria		C$0.00	C$3.93 ▼ C$40.93	C$5.24B	N/A	6.16 million shs	9.61 million shs
MRV Nuvo Pharmaceuticals	C$30.50	C$39.83	C$26.00 ▼ C$53.75	C$27.38B	0.917796	107,818 shs	99,639 shs
VRX Valeant Pharmaceuticals International		C$0.00	C$14.01 ▼ C$36.02	C$10.76B	N/A	1.38 million shs	1.23 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APH Amphenol	0.00%	+5.33%	-2.24%	+12.86%	+54.11%
APHA Aphria	0.00%	0.00%	0.00%	0.00%	0.00%
MRV Nuvo Pharmaceuticals	0.00%	-3.51%	-26.95%	+2,159.26%	+2,159.26%
VRX Valeant Pharmaceuticals International	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APH Amphenol	$157.90 -1.7%	$155.61	$104.71 ▼ $178.52	$194.26B	1.24	9.61 million shs	496,454 shs
APHA Aphria		C$0.00	C$3.93 ▼ C$40.93	C$5.24B	N/A	6.16 million shs	9.61 million shs
MRV Nuvo Pharmaceuticals	C$30.50	C$39.83	C$26.00 ▼ C$53.75	C$27.38B	0.917796	107,818 shs	99,639 shs
VRX Valeant Pharmaceuticals International		C$0.00	C$14.01 ▼ C$36.02	C$10.76B	N/A	1.38 million shs	1.23 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APH Amphenol	0.00%	+5.33%	-2.24%	+12.86%	+54.11%
APHA Aphria	0.00%	0.00%	0.00%	0.00%	0.00%
MRV Nuvo Pharmaceuticals	0.00%	-3.51%	-26.95%	+2,159.26%	+2,159.26%
VRX Valeant Pharmaceuticals International	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APH Amphenol	3.00	Buy	$191.67	21.38% Upside
APHA Aphria	0.00	N/A	N/A	N/A
MRV Nuvo Pharmaceuticals	0.00	N/A	N/A	N/A
VRX Valeant Pharmaceuticals International	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest APH, MRV, VRX, and APHA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2026	APH Amphenol	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$185.00 ➝ $197.00
7/30/2026	APH Amphenol	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$200.00 ➝ $215.00
7/30/2026	APH Amphenol	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$195.00 ➝ $210.00
7/30/2026	APH Amphenol	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$200.00 ➝ $215.00
7/17/2026	APH Amphenol	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B)
7/17/2026	APH Amphenol	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/16/2026	APH Amphenol	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$200.00 ➝ $215.00
7/13/2026	APH Amphenol	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$135.00 ➝ $175.00
7/13/2026	APH Amphenol	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$198.00 ➝ $200.00
7/13/2026	APH Amphenol	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$180.00 ➝ $195.00

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APH Amphenol	$23.09B	8.41	$4.17 per share	37.87	$11.03 per share	14.32
APHA Aphria	C$611.06M	0.00	N/A	22.40	C$4.76 per share	0.00
MRV Nuvo Pharmaceuticals	C$8.72B	3.14	C$135.02 per share	0.23	C$0.75 per share	40.67
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APH Amphenol	$4.27B	$3.99	39.57	26.67	1.30	17.73%	39.87%	14.80%	N/A
APHA Aphria	N/A	-C$2.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MRV Nuvo Pharmaceuticals	C$15.17M	C$2.91	10.48	N/A	N/A	20.95%	1,180.47%	5.85%	N/A
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest APH, MRV, VRX, and APHA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/29/2026	Q2 2026	APH Amphenol	$1.19	$1.35	+$0.16	$1.37	$8.26 billion	$8.76 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APH Amphenol	$1.00	0.63%	+23.60%	25.06%	N/A
APHA Aphria	N/A	N/A	N/A	N/A	N/A
MRV Nuvo Pharmaceuticals	N/A	0.03%	N/A	N/A	N/A
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	N/A

Latest APH, MRV, VRX, and APHA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2026	APH Amphenol	quarterly	$0.25	0.63%	6/23/2026	6/23/2026	7/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APH Amphenol	1.10	1.89	1.41
APHA Aphria	59.29	3.37	1.63
MRV Nuvo Pharmaceuticals	1,165.85	2.11	1.68
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APH Amphenol	97.01%
APHA Aphria	N/A
MRV Nuvo Pharmaceuticals	1.84%
VRX Valeant Pharmaceuticals International	N/A

Insider Ownership

Company	Insider Ownership
APH Amphenol	1.42%
APHA Aphria	N/A
MRV Nuvo Pharmaceuticals	6.32%
VRX Valeant Pharmaceuticals International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APH Amphenol	170,000	1.23 billion	1.21 billion	Optionable
APHA Aphria	1,200	316.80 million	N/A	Not Optionable
MRV Nuvo Pharmaceuticals	N/A	897.54 million	N/A	Not Optionable
VRX Valeant Pharmaceuticals International	N/A	349.30 million	N/A	Not Optionable

APH, MRV, VRX, and APHA Headlines

Recent News About These Companies

Two men charged with kickback scheme at Valeant

June 29, 2026 | uk.finance.yahoo.com

ValueAct slightly ups its position in Valeant Pharmaceuticals

June 26, 2026 | finance.yahoo.com

Valeant Pharma acquires Medicis for US $2.6 billion

May 8, 2025 | pharmaphorum.comP

SCOTUS Passes on Valeant's Challenge to False Claims Act Ruling

October 7, 2024 | news.bloomberglaw.comN

Valeant/Philidor execs convicted of multimillion dollar fraud

October 4, 2024 | pharmaphorum.comP

Valeant Pharmaceuticals International, Inc. v. Silbersher

October 1, 2024 | scotusblog.comS

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

July 28, 2024 | endpts.comE

Kiniksa Pharmaceuticals International PLC Class A

July 26, 2024 | morningstar.comM

Allergan plc Stock Becomes a Buy as It Bottoms Out

April 14, 2024 | aol.comA

Valeant Urges SCOTUS to Clarify Disclosure Rule in Fraud Law

April 11, 2024 | news.bloomberglaw.comN

Valeant Pharmaceuticals International, Inc. (VRX.TO)

February 2, 2024 | finance.yahoo.com

Robbins Umeda LLP Announces an Investigation of the Acquisition of Valeant Pharmaceuticals International by Biovail Corporation

January 4, 2024 | br.advfn.com

Love Him or Hate Him, Ackman Now Runs the Worlds Top Hedge Fund

October 12, 2023 | tradersmagazine.comT

Branded Generics Global Market Report 2023

May 5, 2023 | uk.finance.yahoo.com

Valeant Pharmaceuticals International Stock Hits New 52-Week High (VRX)

March 18, 2023 | thestreet.com

Valeant Pharmaceuticals International Inc (VRX): Today's Featured Health Care Loser

March 10, 2023 | thestreet.com

Valeant Pharmaceuticals International Stock Gaps Up On Today's Open (VRX)

December 26, 2022 | thestreet.com

Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher

August 26, 2022 | thestreet.com

Despite Woes, Valeant May Be Headed for a Rebound

August 22, 2022 | thestreet.com

JPMorgan Picks 7 Pharmaceutical Stocks to Buy (or Hold) in Wake of Interest Rates Hike

April 30, 2022 | thestreet.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

APH, MRV, VRX, and APHA Company Descriptions

Amphenol NYSE:APH

$157.90 -2.80 (-1.74%)

As of 10:07 AM Eastern

Amphenol Corporation, together with its subsidiaries, primarily designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally. It operates through three segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems. The company offers connectors and connector systems, including harsh environment data, power, high-speed, fiber optic, and radio frequency interconnect products; busbars and power distribution systems; and other connectors. It also provides value-add products, such as backplane interconnect systems, cable assemblies and harnesses, and cable management products; other products comprising flexible and rigid printed circuit boards, hinges, other mechanical, and production related products. In addition, the company offers consumer device, network infrastructure, and other antennas; coaxial, power, and specialty cables; and sensors and sensor-based products. It sells its products through its sales force, independent representatives, and a network of electronics distributors to original equipment manufacturers, electronic manufacturing services companies, original design manufacturers, and service providers in the automotive, broadband communication, commercial aerospace, industrial, information technology and data communication, military, mobile device, and mobile network markets. Amphenol Corporation was founded in 1932 and is headquartered in Wallingford, Connecticut.

Aphria TSE:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Nuvo Pharmaceuticals TSE:MRV

C$30.50 0.00 (0.00%)

As of 07/31/2026 03:59 PM Eastern

To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transform-for the better.

Valeant Pharmaceuticals International TSE:VRX

Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest APH, MRV, VRX, and APHA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest APH, MRV, VRX, and APHA Earnings

Compare Dividends

Latest APH, MRV, VRX, and APHA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

APH, MRV, VRX, and APHA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

APH, MRV, VRX, and APHA Company Descriptions

Amphenol NYSE:APH

Aphria TSE:APHA

Nuvo Pharmaceuticals TSE:MRV

Valeant Pharmaceuticals International TSE:VRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools